These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34703368)

  • 1. Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers.
    Bunlung S; Nualnoi T; Issarachot O; Wiwattanapatapee R
    Saudi Pharm J; 2021 Oct; 29(10):1143-1154. PubMed ID: 34703368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of gastroretentive raft forming systems incorporating curcumin-Eudragit® EPO solid dispersions for gastric ulcer treatment.
    Kerdsakundee N; Mahattanadul S; Wiwattanapatapee R
    Eur J Pharm Biopharm; 2015 Aug; 94():513-20. PubMed ID: 26143367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raft-forming gastro-retentive formulations based on Centella asiatica extract-solid dispersions for gastric ulcer treatment.
    Wannasarit S; Mahattanadul S; Issarachot O; Puttarak P; Wiwattanapatapee R
    Eur J Pharm Sci; 2020 Feb; 143():105204. PubMed ID: 31870812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers" [Saudi Pharm. J. 29(10) (2021) 1143-1154].
    Bunlung S; Nualnoi T; Issarachot O; Wiwattanapatapee R
    Saudi Pharm J; 2024 Jan; 32(1):101908. PubMed ID: 38111671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, optimization, and evaluation of raft-forming formulations containing Nizatidine.
    Darwish MKM; Abu El-Enin ASM; Mohammed KHA
    Drug Dev Ind Pharm; 2019 Apr; 45(4):651-663. PubMed ID: 30638411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
    El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
    Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist.
    Prajapati ST; Mehta AP; Modhia IP; Patel CN
    Int J Pharm Investig; 2012 Oct; 2(4):176-82. PubMed ID: 23580933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
    Loh ZC; Elkordy AA
    Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of sustained release floating drug delivery system for norfloxacin: in vitro and in vivo evaluation.
    Guguloth M; Bomma R; Veerabrahma K
    PDA J Pharm Sci Technol; 2011; 65(3):198-206. PubMed ID: 22293231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets.
    Arza RA; Gonugunta CS; Veerareddy PR
    AAPS PharmSciTech; 2009; 10(1):220-6. PubMed ID: 19277869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of floating tablets of liquorice extract.
    Ram HN; Lachake P; Kaushik U; Shreedhara CS
    Pharmacognosy Res; 2010 Sep; 2(5):304-8. PubMed ID: 21589757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet.
    Nagarwal RC; Ridhurkar DN; Pandit JK
    AAPS PharmSciTech; 2010 Mar; 11(1):294-303. PubMed ID: 20182827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation, and
    Patel M; Shelke S; Surti N; Panzade P; Al-Keridis LA; Upadhyay TK; Alshammari N; Saeed M
    Front Pharmacol; 2023; 14():1140351. PubMed ID: 37006995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori.
    El-Zahaby SA; Kassem AA; El-Kamel AH
    Saudi Pharm J; 2014 Dec; 22(6):570-9. PubMed ID: 25561871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
    Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
    PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
    Mandel KG; Daggy BP; Brodie DA; Jacoby HI
    Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel in vitro approach to investigate the effect of food intake on release profile of valsartan in solid dispersion-floating gel in-situ delivery system.
    Himawan A; Djide NJN; Mardikasari SA; Utami RN; Arjuna A; Donnelly RF; Permana AD
    Eur J Pharm Sci; 2022 Jan; 168():106057. PubMed ID: 34743031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of in situ gel of pregabalin.
    Madan JR; Adokar BR; Dua K
    Int J Pharm Investig; 2015; 5(4):226-33. PubMed ID: 26682193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, development, and evaluation of floating pulsatile drug delivery system of atenolol.
    Jagdale SC; Sali MS; Barhate AL; Kuchekar BS; Chabukswar AR
    PDA J Pharm Sci Technol; 2013; 67(3):214-28. PubMed ID: 23752749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.